![](https://ml.globenewswire.com/media/96b902ae-d76d-449d-b50a-8802cec6ce17/small/vigil-logo-tm-002-png.png)
Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
- Sanofi to invest $40 million at an as-converted price of $7.44 per share of common stock- - Sanofi to receive an exclusive right of first negotiation for license of Company’s small molecule TREM2 agonist program, including VG-3927, currently in phase 1 …